Who has invested in NeoTX Therapeutics?

Tako Ventures are named among the investors backing NeoTX Therapeutics.

NeoTX Therapeutics Funding: $60M Raised, Series C (2020)

NeoTX Therapeutics funding overview

NeoTX Therapeutics is based in Rehovot, Israel. NeoTX Therapeutics has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in February 2020. The round record for NeoTX Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Tako Ventures.

NeoTX Therapeutics at a glance

Total raised: $60M
Latest round: Series C
Latest round date: February 2020
Headquarters: Rehovot, Israel
Notable investors: Tako Ventures

Frequently asked about NeoTX Therapeutics funding

How much has NeoTX Therapeutics raised?: NeoTX Therapeutics has raised $60M in total disclosed funding across the rounds on record.
Who has invested in NeoTX Therapeutics?: Tako Ventures are named among the investors backing NeoTX Therapeutics.
What was the latest NeoTX Therapeutics funding round?: The most recent disclosed round is a Series C, announced in February 2020.
Where is NeoTX Therapeutics based?: NeoTX Therapeutics is based in Rehovot, Israel.
When did NeoTX Therapeutics last raise?: The last disclosed NeoTX Therapeutics round closed in February 2020 at Series C.

Totals shown for NeoTX Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Rehovot and the investors behind them below.

NeoTX Therapeutics Funding: $60M Raised, Series C (2020)

NeoTX Therapeutics funding overview

NeoTX Therapeutics at a glance

Frequently asked about NeoTX Therapeutics funding

Companies related to NeoTX Therapeutics (40)

Browse related funding lists (3)